<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li J</submitter><funding>NIA NIH HHS</funding><funding>Eshelman Institute for Innovation, University of North Carolina</funding><funding>National Heart, Lung, and Blood Institute</funding><funding>NHLBI NIH HHS</funding><funding>National Institute of General Medical Sciences</funding><funding>NIGMS NIH HHS</funding><funding>National Institute on Aging</funding><pagination>2026-2035</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8526403</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(10)</volume><pubmed_abstract>Heparan sulfate (HS) 3-&lt;i>O&lt;/i>-sulfotransferase isoform 4 (3-OST-4) is a specialized carbohydrate sulfotransferase participating in the biosynthesis of heparan sulfate. Here, we report the expression and purification of the recombinant 3-OST-4 enzyme and use it for the synthesis of a library of 3-&lt;i>O&lt;/i>-sulfated hexasaccharides and 3-&lt;i>O&lt;/i>-sulfated octasaccharides. The unique structural feature of the library is that each oligosaccharide contains a disaccharide domain with a 2-&lt;i>O&lt;/i>-sulfated glucuronic acid (GlcA2S) and 3-&lt;i>O&lt;/i>-sulfated glucosamine (GlcNS3S). By rearranging the order of the enzymatic modification steps, we demonstrate the synthesis of oligosaccharides with different saccharide sequences. The structural characterization was completed by electrospray ionization mass spectrometry and NMR. These 3-&lt;i>O&lt;/i>-sulfated oligosaccharides show weak to very weak anti-Factor Xa activity, a measurement of anticoagulant activity. We discovered that HSoligo &lt;b>7&lt;/b> (HS oligosaccharide &lt;b>7&lt;/b>), a 3-&lt;i>O&lt;/i>-sulfated octasaccharide, binds to high mobility group box 1 protein (HMGB1) and tau protein, both believed to be involved in the process of inflammation. Access to the recombinant 3-OST-4 expands the capability of the chemoenzymatic method to synthesize novel 3-&lt;i>O&lt;/i>-sulfated oligosaccharides. The oligosaccharides will become valuable reagents to probe the biological functions of 3-&lt;i>O&lt;/i>-sulfated HS and to develop HS-based therapeutic agents.</pubmed_abstract><journal>ACS chemical biology</journal><pubmed_title>Synthesis of 3-&lt;i>O&lt;/i>-Sulfated Heparan Sulfate Oligosaccharides Using 3-&lt;i>O&lt;/i>-Sulfotransferase Isoform 4.</pubmed_title><pmcid>PMC8526403</pmcid><funding_grant_id>R01 HL094463</funding_grant_id><funding_grant_id>R44 HL139187</funding_grant_id><funding_grant_id>R41 HL139187</funding_grant_id><funding_grant_id>R42 GM128484</funding_grant_id><funding_grant_id>RF1 AG069039</funding_grant_id><funding_grant_id>HL144970</funding_grant_id><funding_grant_id>GM134738</funding_grant_id><funding_grant_id>HL139187</funding_grant_id><funding_grant_id>AG069039</funding_grant_id><funding_grant_id>GM123792</funding_grant_id><funding_grant_id>R44 GM123792</funding_grant_id><funding_grant_id>R44 GM134738</funding_grant_id><funding_grant_id>GM128484</funding_grant_id><funding_grant_id>R41 GM123792</funding_grant_id><funding_grant_id>R01 HL144970</funding_grant_id><funding_grant_id>HL094463</funding_grant_id><funding_grant_id>R01 HL062244</funding_grant_id><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Arnold K</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Pagadala V</pubmed_authors><pubmed_authors>Su G</pubmed_authors><pubmed_authors>Xu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Synthesis of 3-&lt;i>O&lt;/i>-Sulfated Heparan Sulfate Oligosaccharides Using 3-&lt;i>O&lt;/i>-Sulfotransferase Isoform 4.</name><description>Heparan sulfate (HS) 3-&lt;i>O&lt;/i>-sulfotransferase isoform 4 (3-OST-4) is a specialized carbohydrate sulfotransferase participating in the biosynthesis of heparan sulfate. Here, we report the expression and purification of the recombinant 3-OST-4 enzyme and use it for the synthesis of a library of 3-&lt;i>O&lt;/i>-sulfated hexasaccharides and 3-&lt;i>O&lt;/i>-sulfated octasaccharides. The unique structural feature of the library is that each oligosaccharide contains a disaccharide domain with a 2-&lt;i>O&lt;/i>-sulfated glucuronic acid (GlcA2S) and 3-&lt;i>O&lt;/i>-sulfated glucosamine (GlcNS3S). By rearranging the order of the enzymatic modification steps, we demonstrate the synthesis of oligosaccharides with different saccharide sequences. The structural characterization was completed by electrospray ionization mass spectrometry and NMR. These 3-&lt;i>O&lt;/i>-sulfated oligosaccharides show weak to very weak anti-Factor Xa activity, a measurement of anticoagulant activity. We discovered that HSoligo &lt;b>7&lt;/b> (HS oligosaccharide &lt;b>7&lt;/b>), a 3-&lt;i>O&lt;/i>-sulfated octasaccharide, binds to high mobility group box 1 protein (HMGB1) and tau protein, both believed to be involved in the process of inflammation. Access to the recombinant 3-OST-4 expands the capability of the chemoenzymatic method to synthesize novel 3-&lt;i>O&lt;/i>-sulfated oligosaccharides. The oligosaccharides will become valuable reagents to probe the biological functions of 3-&lt;i>O&lt;/i>-sulfated HS and to develop HS-based therapeutic agents.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2025-04-04T20:04:13.062Z</modification><creation>2025-04-04T20:04:13.062Z</creation></dates><accession>S-EPMC8526403</accession><cross_references><pubmed>34351732</pubmed><doi>10.1021/acschembio.1c00474</doi></cross_references></HashMap>